Connect with us

Hi, what are you looking for?

Monday, Jun 27, 2022
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.


Canadian government to grant $3M for psilocybin research studies

The aim is to expand the evidence base on psilocybin-assisted psychotherapy to inform practical policies and regulations

Canadian government to grant $3M for psilocybin research studies
Photo via Numinus

Canada’s federal research agency will give researchers $3 million to look into the benefits of using psilocybin to treat mental health illnesses.

Last week, the Canadian Institutes of Health Research (CIHR) launched a grant application to fund psychedelic-assisted psychotherapy research for three specific mental health illnesses.

The research will support Phase 1 or 2 randomized clinical trials relevant to psilocybin use to treat substance use dependence or disorders, major depressive disorder and end-of-life psychological distress in patients with advanced-stage cancer.

The purpose is to strengthen the evidence base and expand research through new clinical trials.

Funding will be provided by the Canadian Drugs and Substances Strategy (CDSS), under the leadership of Health Canada and in partnership with the CIHR Institute of Neurosciences, Mental Health and Addiction (CIHR-INMHA).

“The current funding opportunity will expand the evidence base around psilocybin-assisted psychotherapy to inform practical policies and regulations that aim to improve the health of Canadians and people living in Canada who are experiencing psychiatric disorders,” reads the funding announcement.

Read more: Numinus to enter US psychedelics market via $26.2M Novamind acquisition

Read more: Vancouver Island University to launch Canada’s first psychedelic-assisted therapy graduate program

The total fund of $3 million will be split into three grants, where the maximum amount per grant is $500,000 per year for up to two years for a total of $1 million per grant studying a mental disorder each.

“It is strongly encouraged that people with lived and/or living experience are included in the research team to participate in study design, implementation, knowledge mobilization and/or other aspects of the research process, where appropriate,” reads the funding description.

The registration deadline will run until September 6 and the application deadline ends on October 4. Funding will start at the beginning of March 2023.

The CIHR will host webinars to support applicants with the requirements of this funding and answer questions, with the first one starting on June 9.


Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Follow Natalia Buendia Calvillo on Twitter

Click to comment

Leave a Reply

Your email address will not be published.

You May Also Like

Health and Safety

Science doesn't know yet, but one psychedelic researcher is chasing clues to see if it can


As more medium-to-small producers came into play this year, great weed started hitting legal shelves at fairer prices


Punishments for possession include caning and the death penalty. Despite a global trend of reform, The Fine City remains staunch in its anti-drug stance


While legal weed businesses decry enforcement of their accounts, the platform says it's keeping its all-ages community safe